Ingredion raised its quarterly dividend 1.2 percent to $0.83 per share, extending one of the longer payout records in the food ingredients sector even as the company prepares a $5 billion acquisition of Tate & Lyle. The new rate annualizes to $3.32 per share and yields roughly 3.3 percent at recent prices near $97. Shareholders of record on October 1 will receive the payment on October 20.
What happened with the Ingredion dividend
The board declared the increase on September 17, 2026. The company has now paid and raised its dividend for well over 20 consecutive years, a record that places it in Dividend Aristocrat territory. The pattern has held for more than a decade of annual increases.
The raise adds a single cent to the quarterly payout. That restraint is the signal. Cash is being steered toward the Tate & Lyle acquisition rather than toward dividend acceleration.
Key numbers
| Metric | Figure |
|---|---|
| New quarterly dividend | $0.83 |
| Increase | 1.2 percent |
| Annualized dividend | $3.32 |
| Approximate yield | 3.3 percent |
| Ex-dividend and record date | October 1, 2026 |
| Payment date | October 20, 2026 |
For a $100,000 position at recent prices, the payout generates about $3,300 per year, or roughly $275 per month. The S&P 500 index yields just over 1 percent at current levels, which puts Ingredion’s income near triple the benchmark average.
Earnings support and valuation
Second-quarter results backed the payout. Ingredion reported earnings of $2.82 per share, beating the $2.71 consensus, on revenue of $1.85 billion against a $1.83 billion estimate. Management set full-year 2026 guidance of $10.30 to $10.90 per share, and analysts model $10.76 for the fiscal year.
The stock trades near its 52-week lows at roughly 8 times forward earnings, with a market value of $6.24 billion. Return on equity stands at 15.40 percent, with a net margin of 8.21 percent and a beta of 0.62.
The Tate and Lyle acquisition changes the balance sheet
The dividend’s constraint is the balance sheet. Ingredion is funding the $5 billion all-cash Tate & Lyle purchase with cash, new debt, and a $4.225 billion bridge loan. The deal pushes the company’s debt load toward 3.0 times EBITDA, a level that crowds out faster dividend growth until integration completes.
Coverage remains adequate for now. The payout consumes about 35 percent of earnings. Free cash flow of roughly $355 million covers the approximately $210 million annual dividend about one and a half times, and operating cash flow of $805 million covers it several times over.
Analyst outlook for Ingredion
Wall Street holds a cautious stance on the shares. UBS raised its price target from $104 to $108 while keeping a neutral rating. Oppenheimer downgraded the stock from outperform to market perform in June, and Benchmark reaffirmed a buy. The consensus splits at one buy rating and eight holds.
Risks to watch
- Free cash flow fell roughly 56 percent over the past year, narrowing the cushion under the dividend.
- Integration of Tate & Lyle could stretch costs past current guidance.
- A debt load near 3.0 times EBITDA leaves little room for accelerated payouts or share repurchases.
Bottom line for income investors
The raise keeps the streak alive at a yield near the stock’s historical highs, and the payout looks covered for the near term. The question is not whether Ingredion can pay the dividend today. It is whether the Tate & Lyle integration earns back the debt taken on to fund it. Income buyers get paid to wait at 3.3 percent while that answer arrives.
Stay ahead with our weekly newsletter
Get stock picks, market analysis, and strategy updates delivered to your inbox every week.
Subscribe to AlphaBetaStock’s free newsletter for daily market insights.
